Definium Therapeutics Announces New Employee Grants with Total of 55,580 Options to Purchase Common Shares.

Definium Therapeutics has announced new employee inducement grants, issuing options to purchase 55,580 common shares to three newly hired non-executive employees. The options have an exercise price equal to the closing price of Definium's common shares and will vest over a four-year period. The grants were approved by Definium's Compensation Committee and were made as a material inducement to the employees' employment.